SF1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.120800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.832000E-01
Normal-vs-Stage2
4.010000E-01
Normal-vs-Stage3
1.106030E-01
Normal-vs-Stage4
5.902600E-01
Stage1-vs-Stage2
4.104000E-01
Stage1-vs-Stage3
4.832100E-02
Stage1-vs-Stage4
5.061800E-01
Stage2-vs-Stage3
1.904090E-02
Stage2-vs-Stage4
1.366410E-01
Stage3-vs-Stage4
1.017540E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.135000E-01
Normal-vs-AfricanAmerican
4.621400E-01
Normal-vs-Asian
3.936400E-01
Caucasian-vs-AfricanAmerican
6.733000E-01
Caucasian-vs-Asian
7.411200E-01
AfricanAmerican-vs-Asian
4.680800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.032200E-01
Normal-vs-Female
4.244200E-01
Male-vs-Female
5.580200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.320600E-01
Normal-vs-Age(41-60Yrs)
4.619800E-01
Normal-vs-Age(61-80Yrs)
3.849000E-01
Normal-vs-Age(81-100Yrs)
4.087800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.594450E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
1.836800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.305160E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.024200E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.729000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.649800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.678000E-01
Normal-vs-Daily Drinker
4.502600E-01
Normal-vs-Weekly Drinker
3.847800E-01
Normal-vs-Occasional Drinker
1.617030E-01
Normal-vs-Social Drinker
4.108200E-01
Non Drinker-vs-Daily Drinker
2.191400E-01
Non Drinker-vs-Weekly Drinker
8.292000E-01
Non Drinker-vs-Occasional Drinker
1.962630E-01
Non Drinker-vs-Social Drinker
5.300600E-01
Daily Drinker-vs-Weekly Drinker
3.701000E-01
Daily Drinker-vs-Occasional Drinker
7.669000E-01
Daily Drinker-vs-Social Drinker
5.742600E-01
Weekly Drinker-vs-Occasional Drinker
3.519800E-01
Weekly Drinker-vs-Social Drinker
6.884800E-01
Occasional Drinker-vs-Social Drinker
4.687600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.760400E-01
Normal-vs-Grade 2
6.770400E-01
Normal-vs-Grade 3
6.785000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.607000E-01
Grade 1-vs-Grade 3
6.544800E-01
Grade 1-vs-Grade 4
3.760400E-01
Grade 2-vs-Grade 3
9.699000E-01
Grade 2-vs-Grade 4
6.770400E-01
Grade 3-vs-Grade 4
6.785000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.958400E-01
Normal-vs-NonDiabetic
4.157400E-01
Diabetic-vs-NonDiabetic
6.067000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.710600E-01
Normal-vs-NoPancreatitis
4.061200E-01
Pancreatitis-vs-NoPancreatitis
4.159200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.440200E-01
Normal-vs-N1
3.957600E-01
N0-vs-N1
2.298200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.591600E-01
Normal-vs-TP53-NonMutant
3.814400E-01
TP53-Mutant-vs-TP53-NonMutant
6.556000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
